{
    "nct_id": "NCT06105606",
    "official_title": "Feasibility of the AveCure Microwave Ablation Technology for the Bronchoscopic Treatment of Malignant Central Airway Obstructions",
    "inclusion_criteria": "* Patients age between 18 and 80 years of age and able to provide informed consent.\n* Candidate for bronchoscopy under general anesthesia.\n* Diagnosis of central airway obstruction (trachea, right main stem bronchus, left main stem bronchus), as evidenced by CT or CT/PET imaging confirmed or suspected to be due to malignant etiology, for which the bronchoscopist has deemed that endoscopic ablation/debridement is indicated (i.e. endobronchial tumors, mixed endobronchial/extrinsic compression lesions).\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* Patients who are unable to understand the informed consent, including potential risks and benefits of the procedure.\n* Patients in whom bronchoscopy under general anesthesia is contraindicated.\n* Any comorbidity that the investigator feels would interfere with the safety of the subject or the evaluation of study objectives\n* Pacemaker, implantable cardioverter, or another electronic implantable device\n* Patients with coagulopathy\n* Patients in other therapeutic lung cancer studies\n* COVID-19 positive patient at the time of the procedure.\n* Patients who are pregnant\n* Patients with purely extrinsic compression of the airway.",
    "miscellaneous_criteria": ""
}